Duygu Derin

514 total citations
24 papers, 424 citations indexed

About

Duygu Derin is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Duygu Derin has authored 24 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Duygu Derin's work include Ovarian cancer diagnosis and treatment (4 papers), Glutathione Transferases and Polymorphisms (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Duygu Derin is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Glutathione Transferases and Polymorphisms (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Duygu Derin collaborates with scholars based in Türkiye and United States. Duygu Derin's co-authors include Erkan Topuz, Neşe Güney, Hakan Çamlıca, Hilal Oğuz, Vildan Yasasever, Derya Duranyıldız, Faruk Taş, Adnan Aydıner, Yeşim Eralp and Pınar Saip and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Duygu Derin

24 papers receiving 416 citations

Peers

Duygu Derin
Comparison fields: 5 of 78
  • Oncology 181
  • Molecular Biology 178
  • Cancer Research 81
  • Pulmonary and Respiratory Medicine 79
  • Immunology 60
Ryo Sato Japan
Lorenzo Alonso Spain
Tomoko Ota Japan
V. R. Rozados Argentina
Luis Aparicio Spain
Brittney S. Harrington United States
Janice M. Kraniak United States
Meijin Huang China
Florence Quesada‐Calvo Belgium
Kefeng Wang China
Ryo Sato Japan View profile →
Citations per field, relative to Duygu Derin
Duygu Derin · 1×
Citations per year, relative to Duygu Derin
Duygu Derin · 1×

Countries citing papers authored by Duygu Derin

Since Specialization
Citations

This map shows the geographic impact of Duygu Derin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duygu Derin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duygu Derin more than expected).

Fields of papers citing papers by Duygu Derin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duygu Derin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duygu Derin. The network helps show where Duygu Derin may publish in the future.

Co-authorship network of co-authors of Duygu Derin

This figure shows the co-authorship network connecting the top 25 collaborators of Duygu Derin. A scholar is included among the top collaborators of Duygu Derin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duygu Derin. Duygu Derin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Evaluation of Glutathione S-Transferase P1 Polymorphisms (Ile105Val and Ala114Val) in Patients with Small Cell Lung Cancer Genetic Testing and Molecular Biomarkers Burçak Vural, Fatih Yakar et al. 10
2 Utility of Serum and Urine uPAR Levels for Diagnosis of Breast Cancer Asian Pacific Journal of Cancer Prevention Hilal Oğuz, Derya Duranyıldız et al. 9
3 Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer Genetics and Molecular Research Pınar Saip, Sezer Sağlam et al. 9
4 Pancreatic panniculitis as the first manifestation of the pancreatic involvement during the course of a gastric adenocarcinoma Medical Oncology Cüyan Demirkesen, Duygu Derin et al. 7
5 Effect of Kefir on the Quality of Life of Patients Being Treated for Colorectal Cancer Oncology nursing forum Gülbeyaz Can, Erkan Topuz et al. 18
6 Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. PubMed Neşe Güney, Hilal Oğuz et al. 22
7 Ovarian Carcinoma with Simultaneous Breast and Rectum Metastases Onkologie Duygu Derin, Yeşim Eralp et al. 6
8 Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer International Journal of Clinical Oncology Faruk Taş, Duygu Derin et al. 7
9 A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer International Journal of Clinical Oncology Faruk Taş, Neşe Güney et al. 11
10 Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer Cancer Investigation Duygu Derin, Yeşim Eralp et al. 15
11 Serum levels of angiogenic factors in early breast cancer remain close to normal The Breast Derya Duranyıldız, Hakan Çamlıca et al. 16
12 Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer Investigational New Drugs Erkan Topuz, Duygu Derin et al. 39
13 MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer Annals of Oncology Yeşim Eralp, Duygu Derin et al. 49
14 Serum IL-8 and IL-12 levels in breast cancer Medical Oncology Duygu Derin, Hilal Oğuz et al. 50
15 Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma Lung Cancer Faruk Taş, Duygu Derin et al. 3
16 Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer Investigational New Drugs Faruk Taş, Neşe Güney et al. 14
17 Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer Lung Cancer Duygu Derin, Hilal Oğuz et al. 60
18 Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer Medical Oncology Neşe Güney, Hilal Oğuz et al. 28
19 Serum and Urine Survivin Levels in Breast Cancer Medical Oncology Neşe Güney, Hilal Oğuz et al. 25
20 Isolated Skeletal Muscle Recurrence of the Paranasal Sinus Lymphoma in Complete Remission Medical Oncology Hakan Karagöl, Duygu Derin et al. 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026